<!DOCTYPE html>
<html lang="en">
<head>
    <title>CONTRIBUTING CAUSE: Chemical Imbalances, Neurotransmitters, and Medications</title>
    <meta charset="utf-8">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <meta http-equiv="Cache-Control" content="no-cache, no-store, must-revalidate" />
    <meta http-equiv="Pragma" content="no-cache" />
    <meta http-equiv="Expires" content="0" />
    <link rel="stylesheet" href="../CSS/main.css">
    <link href="https://fonts.googleapis.com/css2?family=Concert+One&display=swap" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Merriweather:400,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.3/css/all.min.css">
    <script src="https://unpkg.com/smoothscroll-anchor-polyfill"></script>
</head>
<!------------------------------->
<!---- chapter-11 ----->
<!------------------------------->
<body>
<div class="summary" id="chapter-11">
  <a href="../Index.html" class="back-to-main-button">
    <i class="fas fa-long-arrow-alt-left"></i></a>
    <h2>CONTRIBUTING CAUSE: Chemical Imbalances, Neurotransmitters, and Medications</h2>
    <!--- TIMELINE LIST --->
<ul>
<!--- section-1 --->
<a href="#section-1">
    <span class="highlighted-text">1. Introduction to Chemical Imbalance Theory</span>
    </ul>
    </a>
<ul>
<!--- section-2 --->
<a href="#section-2">
    <span class="highlighted-text">2. Role of Neurotransmitters and Mitochondria</span>
    </ul>
    </a>
<ul>
<!--- section-3 --->
<a href="#section-3">
    <span class="highlighted-text">3. Serotonin and Its Complex Role</span>
    </ul>
    </a>
<ul>
<!--- section-4 --->
<a href="#section-4">
    <span class="highlighted-text">4. GABA and Dopamine: Functions and Impacts</span>
    </ul>
    </a>
<ul>
<!--- section-5 --->
<a href="#section-5">
    <span class="highlighted-text">5. Psychiatric Medications, Metabolism, and Mitochondria</span>
    </ul>
    </a>
<ul>
<!--- section-6 --->
<a href="#section-6">
    <span class="highlighted-text">6. Valium and Social Dominance in Rats</span>
    </ul>
    </a>
<ul>
<!--- section-7 --->
<a href="#section-7">
    <span class="highlighted-text">7. Impact of Various Medications on Mitochondrial Function</span>
    </ul>
    </a>
<ul>
<!--- section-8 --->
<a href="#section-8">
    <span class="highlighted-text">8. Challenges of Psychiatric Medications</span>
    </ul>
    </a>
<ul>
<!--- section-9 --->
<a href="#section-9">
    <span class="highlighted-text">9. Success Story: Jane—Agitated in the Nursing Home</span>
    </ul>
    </a>
<ul>
<!--- section-10 --->
<a href="#section-10">
    <span class="highlighted-text">10. Summing Up</span>
    </ul>
    </a>
<!-- IN-DEPTH ANALYSIS -->
<!--- section-1 --->
<span class="subheading-text" id="section-1">1. Introduction to Chemical Imbalance Theory</span>
<p>
    The brain energy theory does not dispute that neurotransmitter imbalances play a role in mental disorders or that medications affecting these neurotransmitters can improve symptoms. These assertions are supported by extensive clinical evidence and real-world experiences. However, the chemical imbalance theory leaves many questions unanswered and often fails to restore lives completely. The brain energy theory offers a new perspective by explaining neurotransmitter imbalances and medication effects through the lens of mitochondria and metabolism. Disruptions in mitochondrial function and cellular metabolism can lead to the underactivity or overactivity of brain cells, resulting in the imbalances observed in various mental disorders.
</p>
<!--- section-2 --->
<span class="subheading-text" id="section-2">2. Role of Neurotransmitters and Mitochondria</span>
<p>
    Neurotransmitters are more than simple on/off signals between cells; they play intricate roles in metabolism and mitochondrial function. Research over the past decade has shown that neurotransmitters and mitochondria are in a feedback loop, influencing each other’s balance and function. Mitochondria are involved in the production of neurotransmitters like acetylcholine, glutamate, norepinephrine, dopamine, GABA, and serotonin. Some mitochondria also have receptors for neurotransmitters, such as benzodiazepine and GABA receptors, directly on their membranes. The enzyme monoamine oxidase, located on mitochondria, is involved in the degradation of neurotransmitters like dopamine, epinephrine, and norepinephrine. These interactions highlight the complex relationship between neurotransmitters and mitochondrial function.
</p>
<!--- section-3 --->
<span class="subheading-text" id="section-3">3. Serotonin and Its Complex Role</span>
<p>
    Serotonin is well-known for its role in depression and anxiety disorders, but its influence extends far beyond these conditions. This neurotransmitter is highly conserved across many species and is involved in controlling appetite, digestive functions, and nutrient metabolism. In humans, about 90% of serotonin is located in the digestive tract. Research has shown that serotonin regulates mitochondrial production and function within cortical neurons, enhancing ATP production and reducing oxidative stress. This process also leads to mitochondrial biogenesis, improving overall metabolism. Furthermore, serotonin is converted into melatonin, a hormone critical for regulating sleep and metabolism. The kynurenine pathway, which metabolizes the amino acid tryptophan into serotonin or kynurenine, also influences mitochondrial health. Kynurenine is eventually converted into NAD, a molecule essential for energy production and electron management within mitochondria. Problems in this metabolic pathway are linked to several psychiatric and neurological disorders, including depression, schizophrenia, anxiety disorders, Tourette’s syndrome, and dementia.
</p>
<!--- section-4 --->
<span class="subheading-text" id="section-4">4. GABA and Dopamine: Functions and Impacts</span>
<p>
    GABA is another crucial neurotransmitter, primarily known for its role in anxiety disorders. Medications that increase GABA activity, such as Valium, Klonopin, and Xanax, have calming effects. However, abnormalities in GABA neurotransmission are also found in schizophrenia and autism. Mitochondria influence GABA activity, and research has shown that mitochondrial reactive oxygen species (ROS) levels regulate GABA’s effectiveness. In flies, a genetic defect linked to autism and schizophrenia disrupted GABA sequestration by mitochondria, leading to social deficits. Correcting GABA levels or mitochondrial function reversed these deficits, demonstrating a direct link between mitochondria, GABA, and social behavior.
</p>
<p>
    Dopamine, another key neurotransmitter, is involved in psychosis and addiction. It is usually reabsorbed by the releasing neuron but some of it is managed by mitochondria via the enzyme monoamine oxidase, which degrades it. This degradation process stimulates ATP production in mitochondria. Additionally, dopamine is involved in regulating glucose metabolism. The dopamine D2 receptor, targeted by many antipsychotic medications, is also found in the pancreas, where it influences insulin and glucagon release. This connection helps explain why antipsychotic medications can affect weight, diabetes, and metabolism, and suggests that these effects might contribute to their therapeutic benefits.
</p>
<p>
    These examples illustrate the intricate connections between neurotransmitters, mitochondria, and metabolism, providing a deeper understanding of how psychiatric medications work and their broader implications for mental health treatment.
</p>
<p>
    [Pages 1-4]
</p>
<!--- section-5 --->
<span class="subheading-text" id="section-5">5. Psychiatric Medications, Metabolism, and Mitochondria</span>
<p>
    Psychiatric medications that alter levels of serotonin, GABA, or dopamine impact mitochondria and metabolism through various mechanisms. This includes many classes of antidepressants, anti-anxiety medications, and antipsychotics. For example, Valium is known to reduce anxiety, but its exact mechanism involves enhancing mitochondrial function in specific brain regions.
</p>
<!--- section-6 --->
<span class="subheading-text" id="section-6">6. Valium and Social Dominance in Rats</span>
<p>
    A study on rats investigated how Valium affects anxiety and social dominance behaviors. The researchers found that reduced mitochondrial function in the nucleus accumbens (NAc) caused social anxiety behaviors. Valium was found to activate the ventral tegmental area (VTA), which sends dopamine to the NAc, increasing mitochondrial function and ATP production. This led to reduced anxiety and enhanced social dominance. When the effects of dopamine or mitochondrial respiration were blocked, Valium's therapeutic effects were lost. This study highlighted mitochondrial function as a potential therapeutic target for anxiety-related social dysfunctions.
</p>
<!--- section-7 --->
<span class="subheading-text" id="section-7">7. Impact of Various Medications on Mitochondrial Function</span>
<p>
    Different psychiatric medications affect mitochondria in various ways. Monoamine oxidase inhibitors, a class of antidepressants, increase levels of epinephrine, norepinephrine, and dopamine near mitochondria, stimulating their activity. Lithium, a mood stabilizer, increases ATP production, enhances antioxidant capacities, and improves calcium signaling within cells.
</p>
<p>
    However, many antipsychotic medications are known to cause serious neurological problems, such as tremors, muscle rigidity, and tardive dyskinesia (TD), often due to mitochondrial dysfunction. These medications can decrease energy production and increase oxidative stress at the cellular level. Studies have shown a direct correlation between impaired mitochondrial energy metabolism and TD symptoms in patients with schizophrenia.
</p>
<!--- section-8 --->
<span class="subheading-text" id="section-8">8. Challenges of Psychiatric Medications</span>
<p>
    Psychiatric medications can impair metabolism, leading to side effects like weight gain, metabolic syndrome, diabetes, cardiovascular disease, and even premature death. The dilemma lies in the treatment of hyperexcitable cells: while improving mitochondrial function can help cells repair and function normally, it risks exacerbating symptoms initially. Conversely, inhibiting mitochondrial function can reduce symptoms in the short term but may worsen mitochondrial dysfunction over time.
</p>
<p>
    Medications target specific cells differently, and the overall benefits must be weighed against the risks. For example, in life-threatening situations like seizures, stopping hyperexcitability is crucial even if it impairs mitochondrial function temporarily. Research is needed to better understand these trade-offs and improve treatment approaches.
</p>
<!--- section-9 --->
<span class="subheading-text" id="section-9">9. Success Story: Jane—Agitated in the Nursing Home</span>
<p>
    Early in my career, I worked as a psychiatric consultant in nursing homes. One patient, Jane, an eighty-one-year-old woman with Alzheimer’s disease, was experiencing severe agitation. She had been prescribed five tranquilizing medications, including two antipsychotics, but none were effective. A medical workup found no underlying issues. When I met Jane, she was delirious, likely due to the sedating medications. I recommended stopping as many of these medications as possible, and within three weeks, Jane's condition improved dramatically. Her agitation ceased, and she could have conversations with her sister again. This case illustrates the potential dangers of overmedication and the importance of considering mitochondrial function when treating mental symptoms.
</p>
<!--- section-10 --->
<span class="subheading-text" id="section-10">10. Summing Up</span>
<p>
    -Psychiatric medications have helped countless people with mental disorders and will continue to play a crucial role for many.
</p>
<p>
    -The brain energy theory offers new ways to understand how and why these medications work, highlighting their impact on metabolism and mitochondria.
</p>
<p>
    -It is important to understand the effects of medications on your metabolism and mitochondrial function.
</p>
<p>
    -Medications that enhance metabolism and improve mitochondrial function can alleviate symptoms of underactive cells but may worsen symptoms related to overactive or hyperexcitable cells.
</p>
<p>
    -Medications that impair mitochondrial function should be used cautiously, as they may provide short-term symptom relief but interfere with long-term healing and recovery.
</p>
<p>
    -In dangerous or life-threatening situations, these medications can be lifesaving despite their risks.
</p>
<p>
    Understanding the balance between improving and impairing mitochondrial function can guide better treatment decisions and improve outcomes for individuals with mental disorders.
</p>
<p>
    [Pages 5-9]
</p>

</div>

</body>
<!-- BACK TO TOP BUTTON -->
<button id="button" aria-label="Back to Top">
    <i class="fas fa-arrow-up"></i>
</button>
<!----------------------->
    <script type="module" src="../JS/Functions.js"></script>
</html>
